Survey on MASLD management by Chinese doctors
Part of Digestive system clinical trials.
This study surveys doctors in China about how they manage Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD), a type of fatty liver disease. It aims to understand current practices and improve patient care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a doctor with a valid medical license.
- You work in a Grade IIIA hospital (a top-level hospital in China).
- Your department is Endocrinology, Hepatology, Infection, or Gastroenterology.
- You are an associate chief physician or higher, or a senior attending physician with at least 3 years experience.
- You see at least 20 patients with MASLD per month (if in Endocrinology) or 30 patients (if in Hepatology, Gastroenterology, or Infectious Diseases).
- You are based in a provincial capital or municipality in China.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to build a tool to predict how MASLD-related cirrhosis (fatty liver disease leading to liver scarring) will progress. It may help doctors and patients better understand the outlook and plan care.
This study looks at whether the natural chemicals made by your gut bacteria from the food you eat could affect liver fat and health. If you have MASLD (a fatty liver condition), researchers want to measure these gut-produced substances to better understand the disease.
This study looks at factors that predict liver cancer and the need for a liver transplant in people with a liver condition called MASLD (metabolic dysfunction-associated steatotic liver disease). The goal is to better understand the disease and improve care.
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.
This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.
Hear when a new Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.